Description

Renovelli® PMMA

Contains: 6ml*  2 syringes with 3ml

•         Revolutionary on security, lasting time and comfort
•         Up to 10 Years Younger
•         PMMA Polymethylmethacrylate 10%
•         2% Lidocaine

INJECTABLE IMPLANT BIOLOGICALLY INERT LONG TERM

The first injectable implant containing polymethylmethacrylate microspheres (PMMA) was developed in Germany for more than 20 years. Continued studies and improvements have resulted in the third and current generation of Acquafiller implants. The first generation started in Germany in the 1990s proved to be effective, although it provoked some adverse reactions [1-2]. Most of these reactions were caused by nodules at the sites of injection, occasionally associated with the inflammatory response. Further investigation has led to the conclusion that there is a specific limit of the diameter of the PMMA microspheres, which is fundamental to avoid adverse reactions. Investigations and scientific literature published from these studies suggest that PMMA microspheres below 20 μ in diameter may trigger a foreign body reaction .